DOW
Dow Inc
NYSE · Chemicals
$31.78
+1.18 (+3.86%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 43.72B | 47.46B | 11.75B | 12.07B | 13.10B |
| Net Income | 1.14B | 1.11B | 934.71M | 1.15B | 1.41B |
| EPS | — | — | — | — | — |
| Profit Margin | 2.6% | 2.5% | 8.0% | 9.5% | 10.8% |
| Rev Growth | -7.9% | -7.9% | -9.0% | +20.5% | -2.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 5.53B | 5.53B | 3.26B | 3.27B | 3.76B |
| Total Equity | 5.87B | 5.87B | 14.55B | 16.36B | 14.86B |
| D/E Ratio | 0.94 | 0.94 | 0.22 | 0.20 | 0.25 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 2.62B | 2.70B | 1.66B | 1.76B | 1.70B |
| Free Cash Flow | — | — | 1.14B | 1.48B | 1.41B |